(Q26252115)

8 January 2018

editorial

0 references

title

Research and development of Zika virus vaccines (English)

1 reference

8 January 2018

0 references

0 references

0 references

6

Lisa M Reece

Lisa M

Reece

1 reference

8 January 2018

Brian E Dawes

1

Brian E

Dawes

1 reference

20 October 2023

5

Gregg N Milligan

Gregg N

Milligan

1 reference

8 January 2018

7

Joachim Hombach

Joachim

Hombach

1 reference

8 January 2018

8

Alan Dt

Barrett

Alan Dt Barrett

1 reference

8 January 2018

Claire A Smalley

2

Claire A

Smalley

1 reference

8 January 2018

Bethany L Tiner

series ordinal

3

author given names

Bethany L

author last names

Tiner

1 reference

8 January 2018

David Wc Beasley

series ordinal

4

author given names

David Wc

author last names

Beasley

1 reference

8 January 2018

language of work or name

1 reference

28 July 2016

1 reference

8 January 2018

published in

NPJ Vaccines

1 reference

8 January 2018

volume

1

1 reference

8 January 2018

issue

1

0 references

page(s)

16007

1 reference

8 January 2018

Creative Commons Attribution 4.0 International

copyright license

start time

28 July 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

on focus list of Wikimedia project

WikiProject Zika Corpus

0 references

cites work

Zika virus. I. Isolations and serological specificity

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

A report on the outbreak of Zika virus on Easter Island, South Pacific, 2014

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Aedes (Stegomyia) albopictus (Skuse): a potential vector of Zika virus in Singapore

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus. II. Pathogenicity and physical properties

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Meet dengue's cousin, Zika

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Molecular evolution of Zika virus during its emergence in the 20(th) century

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Phylogeny of Zika Virus in Western Hemisphere, 2015

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika Virus in the Americas — Yet Another Arbovirus Threat

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus in the Americas: Early epidemiological and genetic findings

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus in Gabon (Central Africa)--2007: a new threat from Aedes albopictus?

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika Virus Outbreak on Yap Island, Federated States of Micronesia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Concurrent Chikungunya and Dengue Virus Infections during Simultaneous Outbreaks, Gabon, 2007

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika Virus, French Polynesia, South Pacific, 2013

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Detection of Zika virus in urine

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

First report of autochthonous transmission of Zika virus in Brazil

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Detection of Zika Virus Infection in Thailand, 2012-2014

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus infection, Philippines, 2012

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus genome from the Americas

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika Virus Outbreak in Haiti in 2014: Molecular and Clinical Data

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Comparative genomic analysis of pre-epidemic and epidemic Zika virus strains for virological factors potentially associated with the rapidly expanding epidemic

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus: further isolations in the Zika area, and some studies on the strains isolated

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

A sero-epidemiological survey for certain arboviruses (Togaviridae) in Pakistan

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika Virus: Medical Countermeasure Development Challenges

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika Virus: Emergence and Emergency

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Male-to-Male Sexual Transmission of Zika Virus — Texas, January 2016

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika cases climb to 147 in US and Puerto Rico

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Characterization of a Novel Murine Model to Study Zika Virus

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

History, Epidemiology, and Clinical Manifestations of Zika: A Systematic Review

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus and microcephaly: why is this situation a PHEIC?

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus in Brazil and macular atrophy in a child with microcephaly

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Initial Description of the Presumed Congenital Zika Syndrome

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Possible Association Between Zika Virus Infection and Microcephaly — Brazil, 2015

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika Virus and Birth Defects — Reviewing the Evidence for Causality

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

CNS infections: Zika virus infection could trigger Guillain–Barré syndrome

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus and neurologic autoimmunity: the putative role of gangliosides

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Guillain-Barré syndrome associated with the Zika virus outbreak in Brazil

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Detection of Zika virus in saliva

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

First case of Zika virus infection in a returning Canadian traveler

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus outbreak: an overview of the experimental therapeutics and treatment

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus, a cause of fever in Central Java, Indonesia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

The 3.8 Å resolution cryo-EM structure of Zika virus

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Zika virus NS1 structure reveals diversity of electrostatic surfaces among flaviviruses

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Mouse models of dengue virus infection for vaccine testing

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

A Susceptible Mouse Model for Zika Virus Infection

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

A Mouse Model of Zika Virus Pathogenesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Characterization of Lethal Zika Virus Infection in AG129 Mice

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

A rhesus macaque model of Asian-lineage Zika virus infection

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

WHO reveals its shopping list for weapons against Zika

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

The dengue vaccine pipeline: Implications for the future of dengue control

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/NPJVACCINES.2016.7

Structure of the thermally stable Zika virus

21 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Zika Virus: Implications for Public Health

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Notes from the Field : Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses — Brazil, 2015

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Identification of Zika virus vectors and implications for control

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Nucleic acid (DNA) immunization as a platform for dengue vaccine development

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Next generation dengue vaccines: A review of the preclinical development pipeline

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Dengue virus vaccine development

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, South India, 2005-10

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

31 May 2018

Kyasanur forest disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

New Japanese encephalitis vaccines: alternatives to production in mouse brain

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Biology and pathogenesis of chikungunya virus

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Correlates of protection induced by vaccination

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Spondweni virus infection in a foreign resident of Upper Volta

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5707891

Vaccine manufacturing: challenges and solutions

31 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJVACCINES.2016.7

Vaccine protection against Zika virus from Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJVACCINES.2016.7

Development of Sanofi Pasteur tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPJVACCINES.2016.7

inferred from DOI database lookup

7 January 2021

based on heuristic

Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNPJVACCINES.2016.7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NPJVACCINES.2016.7

1 reference

8 January 2018

Dimensions Publication ID

0 references

1 reference

8 January 2018

PubMed publication ID

29263851

1 reference

8 January 2018